1. Lachmann B, Danzmann E (1984) Acute respiratory distress syndrome. In: Robertson B, Golde LMG, Batenburg JJ (eds) Pulmonary surfactant. Elsevier, Amsterdam
2. Hein T, Lachmann B, Armbruster S, Smit JM, Voelkel N, Erdmann W (1987) Pulmonary surfactant inhibits the cardiovascular effects of platelet activating factor (PAF), 5-hydroxytryptamine (5-HT) and angiotensin II. Am Rev Respir Dis 135: A506
3. Lachmann B (1985) Possible function of bronchial surfactant. Eur J Respir Dis 67: 49–61
4. Green GM (1973) Alveolobronchiolar transport mechanisms. Arch Intern Med 31: 109–114
5. Reifenrath R (1983) Surfactant action in bronchial mucus. In: Cosmi EV, Scarpelli EM (eds) Pulmonary surfactant system. Elsevier, Amsterdam, pp 339–347